What Happened?
, -based Affinivax Appointed Ken Kobus as Senior Director, Head of Supply Chain
About the Company
Affinivax is a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines designed to induce a broad and robust protective immune response to both disease-relevant polysaccharides and disease-relevant proteins in a single vaccine. Affinivax designs each of its vaccine candidates to optimize the protective immune response to one or both of these antigens utilizing the distinctive plug-and-play nature of its proprietary MAPS™ technology platform, presenting the potential opportunity to make a significant step forward in addressing major healthcare challenges posed by novel and resistant infectious diseases. Affinivax was founded in 2014 with a seed investment from the Bill & Melinda Gates Foundation and an exclusive license to the MAPS technology from Boston Children`s Hospital.
About the Person
Ken Kobus is Senior Director, Head of Supply Chain at Affinivax. Previously, Ken held various senior HR leadership roles in the industry.
Info Source
News
Short Profile